Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

BUILDING A BUSINESS

Mapping the European startup landscape

A deep dive into the influence of research output, patenting, venture capital and human capital on startup financing activity in Europe reveals not all countries are equal.

This is a preview of subscription content

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1: Distribution of startup deals among European countries.
Fig. 2: Biomedical research output differences across Europe.
Fig. 3: Biomedical patent differences across Europe.
Fig. 4: The number of biomedical VC companies across Europe.
Fig. 5: Human capital across Europe for biotech startups.
Fig. 6: Relationship between the number of startup deals and scientific output, patents or VC presence across Europe.

References

  1. 1.

    Alstadsæter, A., Barrios, S., Nicodeme, G., Skonieczna, A.M. & Vezzani, A. European Commission IPTS Working Papers on Corporate R&D and Innovation – No. 6/2015, Patent boxes design, patents location and local R&D. https://ec.europa.eu/jrc/sites/jrcsh/files/JRC96080_Patent_boxes.pdf (2015).

  2. 2.

    Stevens, A. J. Nat. Biotechnol. 35, 608–613 (2017).

    CAS  Article  Google Scholar 

  3. 3.

    Acs, Z.J., Szerb, L. & Lloyd, A. 2017 Global Entrepreneurship Index http://thegedi.org/product/2017-global-entrepreneurship-index/ (2017).

  4. 4.

    Liñán, F. & Fernandez-Serrano, J. Small Bus. Econ. 42, 685–701 (2014).

    Article  Google Scholar 

  5. 5.

    Rooswinkel, R. W., Berbers, D. S. W., Claassen, E. H. J. H. M. & van Deventer, S. Nat. Biotechnol. 34, 1095–1098 (2016).

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Rogier W. Rooswinkel.

Ethics declarations

Competing interests

B.v.W., S.v.D. and R.W.R. are employed by Forbion Capital Partners, which invests in biotech ventures.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Supplementary Information

Supplementary Methods and Supplementary Tables 1 and 2

Supplementary Data

Raw data for the European analysis

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

van Wilgenburg, B., van Wilgenburg, K., Paisner, K. et al. Mapping the European startup landscape. Nat Biotechnol 37, 345–349 (2019). https://doi.org/10.1038/s41587-019-0076-4

Download citation

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing